期刊文献+

301例透析患者不安腿综合征相关因素研究 被引量:9

Related Factors Associated with Restless Legs Syndrome in 301 Patients Undergoing Dialysis
下载PDF
导出
摘要 目的:对透析患者进行调研,旨在发现与尿毒症不安腿综合征(uremic restless legs syndrome,u-RLS)发病有关的因素。方法:用流行病学现场调查方法,收集301例透析患者的一般情况、实验室检验及检查结果、临床不适主诉。根据年龄、性别、透析龄、透析方式(腹膜透析、血液透析)进行比配,设计病例对照研究(共225例),分为不安腿阳性组(76例)及阴性组(149例),比较两组间差异,并通过多因素分析方法分析各因素与u-RLS之间的相关性。在匹配的患者中,根据有无糖尿病,分为糖尿病亚组(44例)及非糖尿病亚组(181例),分别分析两组中不安腿与各个因素之间的关系。结果:在比配的225例病例及非糖尿病亚组中,均提示:失眠、肢体麻木、血肌酐、血β_2微球蛋白(β_2-MG)、血清钙,血清甲状旁腺激素水平(parathyroidmone,PTH)、血清铁蛋白、血清维生素B12浓度与u-RLS差异有统计学意义(P<0.05),Logistic回归分析提示PTH、血肌酐、血清铁蛋白、血β_2-MG、血清维生素B12浓度是u-RLS发病的独立因素(P<0.05)。在糖尿病亚组中,失眠、肢体麻木、血清维生素B12浓度、血清铁蛋白与u-RLS差异有统计学意义(P<0.05),血清维生素B12浓度、血清铁蛋白是u-RLS发病的独立因素(P<0.05)。结论:尿毒症不安腿综合征与失眠、肢体麻木的共病可能性大;小分子毒素(血肌酐)、中大分子毒素(PTH、β_2-MG)水平与尿毒症不安腿综合征的发生呈正相关;血清铁蛋白水平、血清维生素B12浓度与尿毒症不安腿综合征的发生呈负相关。 Objective:To find the factors associated with the onset of the restless legs syndrome in patients with uremia. Methods: Hemodialysis patients and peritoneal dialysis patients were collected with the method of epidemiological field survey. The to- tal number of cases was 301. It was the general condition, laboratory inspection, inspection results, and chief complaints of clinical discomfort that mainly had been collected. Patients were compared and matched on the basis of ages, sexes, dialysis ages and dialysis methods ( peritoneal dialysis and hemodialysis), which provided information for the design of case - control study. They were then di- vided into the positive group (RLS group) and the negative group (NRLS group) of restless legs, which contained 76 cases of RLS group and 149 cases of NRLS group. Apart from the comparison between two groups, the correlation between various factors and the uremic with restless legs syndrome was analyzed by means of multivariate methods. According to whether there was diabetes mellitus a- mong matched patients, patients were divided into the diabetes group (44 cases) and non - diabetes group ( 181 cases). Differences between two groups were compared. Results : Both 225 compared and matched ease and the non - diabetes group provide the informa- tion that the inter - group differences among insomnia, limb numbness, serum creatinine, serum ~2 - microglobulin, serum calcium, the lever of serum parathyroid hormone (FrH) , serum ferritin and the concentration of serum vitamin B12 exert statistical significance on the research (P 〈 0.05 ). Logistic regression analysis has shown that PTH, serum creatinine, serum ferritin, serum 132 - micro- globulin and the concentration of serum vitamin B12 are independent factors of the uremia restless legs syndrome, In diabetes group, the inter- group differences among insomnia, limb numbness, the concentration of serum vitamin B12 and serum ferritin are of statis- tical significance (P 〈 0.05 ). The conce
出处 《中国中西医结合肾病杂志》 2017年第3期225-229,共5页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 杭州市科技计划项目(No.20140733Q33) 浙江省自然科学基金资助项目(No.Y2101410) 浙江省中医药科技计划项目(No.2013ZA091) 杭州市卫生局重点项目(No.2011Z013)
关键词 肾透析 临床流行病学 不安腿综合征 相关因素 Renal dialysis Clinical epidemiology Restless legs syndrome Related factors
  • 相关文献

参考文献7

二级参考文献74

  • 1邬碧波,张黎明,唐琦,贾洁爽,芦怡舟.蔗糖铁治疗维持性血液透析患者不安腿综合征的临床观察[J].中国血液净化,2012,11(9):480-484. 被引量:9
  • 2谢红浪,季大玺.On-line hemodiafiltration技术和临床应用[J].肾脏病与透析肾移植杂志,2005,14(4):377-381. 被引量:25
  • 3李春玲,王丽华,郝丽荣.不宁腿综合征在血液透析患者中的研究进展[J].牡丹江医学院学报,2005,26(6):53-55. 被引量:12
  • 4[1]Sato T, Shoji H, Koga N. Endotoxin adsorption by polymyxin B immo bileized fiber column in patients with systemic inflammatory rssponse syndrome: The Japanese Experiense, Therapeutic Apheresis and Dialysis,2003,7(2) :252 - 258 被引量:1
  • 5[2]Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis:Endotoxin adsorption cartridge(Toraymyxin). Therapeutic Apheresis and Dialysis, 2003,7(1):108 - 114 被引量:1
  • 6[3]Schmaldienst S, Banyai S, Stulnig TM, et al. Prospective randomised cross- over comparison of three LDL - apheresis system in stain pretreated patients with familial hypercholesterolaemia. Athernsclerosis,2000,151(2) :493 - 7 被引量:1
  • 7[4]Ritter M. M, Parhofer K.G. Extracorporal low - density lipoprotein by innunoadsorption. Therapeutic Apheresis and Dialysis, 2003, 7 ( 3 ):370 - 372 被引量:1
  • 8[5]Nakaji S, Haynshi N. Adsorption for myasthenia gravis treatment:Medisorba MG - 50. Therapeutic Apheresis and dialysis, 2003,7 ( 1 ):78 - 84 被引量:1
  • 9[6]Hirata N, Kuriyama T, Yamawaki N. Immusorba TR and PH. Therapeutic Apheresis and Dialysis, 2003,7( 1 ) :85 - 90 被引量:1
  • 10[7]Bambauer R,Schiel R, Latza R,et al. LDL apheresis in clinical practice: long - term treatment of severe hyperlipidemia. Ther Apher, 1997,1(1): 49-51 被引量:1

共引文献49

同被引文献71

引证文献9

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部